Dr. Petrasko's research involves various heart conditions and the treatments associated with them. He studies conditions like recurrent idiopathic pericarditis, where patients have chest pain due to inflammation around the heart, and myocarditis, which is an inflammation of the heart muscle, often linked to infections like COVID-19. He also examines the risks associated with medications, particularly in patients with ADHD and those undergoing heart procedures, helping to personalize treatments based on genetic factors. His work aims to improve safety and effectiveness in managing heart conditions, particularly in vulnerable populations such as pregnant women and patients with unique genetic profiles.
Key findings
A case study documented a 25-year-old woman with recurrent idiopathic pericarditis who had a flare-up after stopping anakinra during pregnancy but improved upon resuming it, demonstrating the importance of medication management in pregnant patients.
Research on 868 patients revealed that adjusting anti-platelet medication based on genetic testing resulted in no significant differences in heart attack rates or bleeding events after heart procedures.
In a study with a 67-year-old man, heart function due to COVID-19-related myocarditis did not improve over three months of treatment, leading to the implantation of an ICD for sudden cardiac death prevention.
Use of a new ultra-low contrast delivery technique during coronary procedures reduced the average contrast dye used significantly from 42.3 mL to 24.8 mL, thereby lowering potential complications.
Understanding spontaneous coronary artery dissection (SCAD) as a significant risk for young women, especially postpartum, and better imaging techniques improved diagnosis to enhance patient outcomes.
Frequently asked questions
Does Dr. Petrasko study conditions like recurrent idiopathic pericarditis?
Yes, he focuses on recurrent idiopathic pericarditis and its management, particularly in women during pregnancy.
What treatments has Dr. Petrasko researched for heart conditions?
He has researched various treatments including the use of anakinra for pericarditis, anti-platelet therapy tailored by genetic testing, and interventional procedures like coronary angioplasty.
Is Dr. Petrasko's work relevant to patients with heart issues from COVID-19?
Absolutely, his research addresses heart problems caused by COVID-19, such as myocarditis, and explores necessary interventions.
Does Dr. Petrasko look at medication risks for patients?
Yes, he examines the risks associated with medications, especially stimulants for ADHD and anti-platelet agents in cardiovascular disease.
How does Dr. Petrasko's research help pregnant women?
His studies provide insight into managing heart conditions during pregnancy, ensuring safer treatment options for women with complex heart issues.
Publications in plain English
Relapse of colchicine-intolerant, corticosteroid-dependent recurrent idiopathic pericarditis after perigestational discontinuation of anakinra: uncertain safety of anakinra in pregnancy and the need for shared decision-making.
2023
BMJ case reports
Saad Shaukat MH, Fiegen N, Malik MN, Petrasko M
Plain English A 25-year-old woman with a heart condition called recurrent idiopathic pericarditis, who couldn't take colchicine and relied on steroids, was stable for two years while using a drug called anakinra. When she unexpectedly became pregnant, she stopped taking anakinra and soon experienced a painful flare-up of her condition, but symptoms improved after she resumed the drug. Although there were concerns about the safety of anakinra during pregnancy, she ultimately delivered a healthy baby at 34 weeks.
Who this helps: This information benefits pregnant women with recurrent idiopathic pericarditis and their doctors.
Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA) in a Patient Taking Lisdexamfetamine.
2022
South Dakota medicine : the journal of the South Dakota State Medical Association
Perinkulam Sathyanarayanan S, Hamza Saad Shaukat M, Wilson J, Petrasko M
Plain English This study looked at a 52-year-old man who experienced sudden chest pain while taking a medication called lisdexamfetamine for ADHD. Doctors found that he had signs of a heart attack, but when they examined his blood vessels, they discovered there were no blockages. This case is important because it shows that even with normal heart arteries, stimulant medications can still lead to serious heart problems.
Who this helps: This information can help doctors better understand the risks associated with stimulant medications for patients with ADHD.
CYP2C19 genotype-directed PYinhibitor antiplatelet therapy normalizes risk for major adverse cardiovascular events after percutaneous coronary intervention.
2021
Indian heart journal
Stys TP, Gedela M, Gowda SN, Bares V, Fanta L +4 more
Plain English This study looked at how using genetic testing for the CYP2C19 gene can help doctors choose the best anti-platelet medication for patients who have undergone heart procedures. Researchers analyzed 868 patients and found that those who had their medication adjusted based on their genetic results did not experience worse outcomes from major heart issues over a year, with no significant differences in heart attacks or bleeding events. This research matters because it shows that personalized medication choices can be effective for improving patient care after heart procedures.
Who this helps: Patients recovering from heart procedures.
Index Case of COVID-19 Myocarditis Requiring BiV-ICD for Primary Prevention of Sudden Cardiac Death.
2021
South Dakota medicine : the journal of the South Dakota State Medical Association
Saad Shaukat MH, Petrasko P, Petrasko M, Rynders B, Pham S
Plain English This study focused on a 67-year-old man who developed heart problems due to COVID-19, specifically a serious condition called myocarditis that led to very low heart function, with an ejection fraction as low as 15-20%. Despite receiving the best available treatments, his heart function did not improve over three months, so doctors decided to implant a special device called an implantable cardioverter-defibrillator (ICD) to help prevent sudden cardiac death. This case is important because it highlights the severe impact COVID-19 can have on heart health and the need for specific interventions when standard treatments fail.
Who this helps: This helps doctors and patients dealing with COVID-related heart issues.
Bioengineering the Oxygen-Deprived Tumor Microenvironment Within a Three-Dimensional Platform for Studying Tumor-Immune Interactions.
2020
Frontiers in bioengineering and biotechnology
Bhattacharya S, Calar K, Evans C, Petrasko M, de la Puente P
Plain English This study looked at how low oxygen levels in tumors affect breast cancer cells and their interaction with the immune system. Researchers created a special three-dimensional model that mimicked the oxygen conditions found in healthy and cancerous breast tissue. They found that low oxygen levels led to less growth of breast cancer cells and made it harder for immune cells, particularly CD8+ T cells, to infiltrate tumors, highlighting the importance of oxygen in cancer treatment.
Who this helps: This helps patients by improving strategies for cancer therapies.
Robotic-Assisted Percutaneous Coronary Intervention Through Transradial Approach: Experience in 4 Patients with Complex Lesions.
2020
Texas Heart Institute journal
Anuwatworn A, Ali Kahn M, Stys T, Petrasko M, Stys A
Plain English This study examined the use of robotic-assisted techniques for a heart procedure called percutaneous coronary intervention, specifically using a method that accesses the arteries through the wrist instead of the groin. The researchers treated four patients with complex heart artery blockages, successfully performing balloon angioplasty to reopen these arteries. This is important because it shows that robotic assistance can enhance safety and effectiveness for challenging cases without the usual risks associated with traditional methods.
Who this helps: Patients with complex heart artery blockages.
Current Evidence and Rationale of Percutaneous Therapy for Chronic Total Coronary Occlusions.
2019
Current problems in cardiology
Bhatnagar UB, Shrestha A, Petrasko M, Stys TP, Stys AT
Plain English This study looked at the treatment of chronic total occlusions (CTOs) in coronary arteries, which are blockages that can cause serious heart problems. Researchers found that newer techniques have significantly increased success rates for treating these blockages, with benefits like reduced chest pain (angina) reported in recent trials, although the results can vary across different studies. This matters because better treatment for CTOs can lead to improved quality of life for patients with heart issues.
Who this helps: Patients with chronic coronary artery disease.
Retained Coronary Balloon Requiring Emergent Open Surgical Retrieval: An Uncommon Complication Requiring Individualized Management Strategies.
2019
Methodist DeBakey cardiovascular journal
Desai CK, Petrasko M, Steffen K, Stys T, Stys A
Plain English The study focused on a rare complication that can happen during heart procedures when a balloon used to treat arteries gets stuck inside a blood vessel. In the reported case, doctors had to perform open-heart surgery to retrieve a balloon that had become trapped, highlighting the importance of having different strategies to manage this problem. The researchers discussed several alternative methods to try before considering surgery, which can be risky and complicated.
Who this helps: This information benefits doctors who perform heart procedures to ensure safer outcomes for their patients.
A prospective study of contrast preservation using ultra-low contrast delivery technique versus standard automated contrast injector system in coronary procedures.
2019
Indian heart journal
Stys A, Gedela M, Bhatnagar U, Petrasko M, Dawoud H +2 more
Plain English This study looked at how much contrast dye is used during heart procedures when using a new method called the ultra-low contrast delivery technique (ULCD) compared to the traditional automated injector system. The researchers found that ULCD significantly reduced the amount of contrast dye used: for heart angiograms, it dropped from an average of 42.3 mL to 24.8 mL, and for other procedures, it decreased from 48.2 mL to 23.5 mL. This is important because using less contrast dye can lower the risk of potential complications for patients.
Who this helps: Patients undergoing heart procedures may benefit from reduced contrast dye exposure and the associated risks.
Clinical factors associated with physician choice of femoral versus radial access: A real-world experience from a single academic center.
2018
Journal of interventional cardiology
Yee J, Kumar V, Li S, Petraskova T, Pham A +5 more
Plain English This study looked at why doctors choose either femoral (in the groin) or radial (in the wrist) access for heart procedures, based on data from over 11,200 cases. It found that doctors preferred femoral access for emergency situations like heart attacks and in patients over 70, while radial access was favored for younger and morbidly obese patients. Radial access showed benefits in lower radiation exposure and less contrast dye used overall, which is important for patient safety and recovery.
Who this helps: This research benefits heart patients and doctors by guiding better access choices during procedures.
Simultaneous Onset of Deep Vein Thrombosis, Pulmonary Embolism, Cerebral Infarction, and Myocardial Infarction in a Patient with Patent Foramen Ovale.
2017
South Dakota medicine : the journal of the South Dakota State Medical Association
Yee J, Kumar V, Pham A, Shaikh K, Omar M +2 more
Plain English This study looked at a patient who experienced multiple serious blood clots at once—specifically, in the veins, lungs, heart, and brain—due to a heart condition called a patent foramen ovale, which is a small hole in the heart. The patient received medication to dissolve the clots, but doctors had to carefully manage the situation because there was a risk of bleeding in the brain. This case shows how important it is for doctors to evaluate the whole body when diagnosing and treating complex conditions like this.
Who this helps: This helps doctors and patients dealing with serious blood clot issues.
Spontaneous Coronary Artery Dissection: A Rare Manifestation of Alport Syndrome.
2017
Case reports in cardiology
Anuwatworn A, Sethi P, Steffen K, Jonsson O, Petrasko M
Plain English This study focuses on a rare case of spontaneous coronary artery dissection (SCAD) in a 36-year-old woman with Alport syndrome, a genetic disorder that affects the kidneys, hearing, and vision. The patient came to the emergency room with severe chest pain, and tests showed a problem with her heart artery, which was successfully treated with a procedure called angioplasty. This finding emphasizes that patients with Alport syndrome could also experience serious heart issues, like SCAD, not typically associated with the condition.
Who this helps: This helps patients with Alport syndrome and their doctors by raising awareness of potential heart problems.
New Oral Anticoagulants: What Prescribers Should Know; Differences and Similarities between Warfarin and "New Agents" (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) - Review of Indications, Contraindications and Safety of Use.
2016
South Dakota medicine : the journal of the South Dakota State Medical Association
A Primer on Bleeding Risk and Management Strategies of Newer Oral Anti Platelet Agents in Cardiovascular Disease.
2016
South Dakota medicine : the journal of the South Dakota State Medical Association
Yee J, Kumar V, Anuwatworn A, Petrasko M, Stys A
Plain English This research paper looks at newer oral medications that help prevent blood clots in patients with heart disease, specifically focusing on the risks of bleeding these medications can cause. It summarizes the history of these drugs, like Clopidogrel and newer agents approved in the last seven years, and emphasizes that while these medications are effective, they also have heightened risks for side effects. This information is important for doctors so they can make informed decisions about using these medications safely.
Who this helps: This helps doctors and patients with cardiovascular disease.
Postpartum Spontaneous Coronary Artery Dissection An Uncommon Cause of Acute Coronary Syndrome.
2015
South Dakota medicine : the journal of the South Dakota State Medical Association
Raizada A, Petrasko M
Plain English This study looked at a rare heart condition known as spontaneous coronary artery dissection (SCAD), which mainly affects young women, especially those who have recently given birth. Researchers found that new imaging techniques like intravascular ultrasound can help diagnose SCAD more accurately than traditional methods, as they reveal details that other tests might miss. Understanding and diagnosing SCAD is important because it can lead to serious heart issues, and knowing about it can improve patient care.
Who this helps: This helps young women, especially new mothers, who might experience this serious heart condition.
Complete first generation drug eluting stent fracture and yet another quantum leap in interventional cardiology.
2015
South Dakota medicine : the journal of the South Dakota State Medical Association
Khan M, Stys A, Stys T, Rajpurohit N, Petrasko M
Plain English This study looked at the problem of fractures in drug-eluting stents, which are used to keep coronary arteries open. It found that these fractures happen more often with a specific type of stent called Cypher, but not all fractures cause serious health issues. The researchers concluded that doctors shouldn't routinely check for stent fractures since many don't lead to significant problems.
Who this helps: This helps doctors decide when to monitor stent fractures, ultimately benefiting patients who receive stents.
Implementing the 2013 cholesterol management guidelines into clinical practice.
2015
South Dakota medicine : the journal of the South Dakota State Medical Association
Kelly SC, Li S, Petrasko M
Plain English This article explains the 2013 ACC/AHA cholesterol guidelines, which shifted the focus from hitting a specific LDL number to ensuring the highest-risk patients receive the most effective statin therapy. A new risk calculator was introduced to identify who needs treatment, and routine stopping of statins solely due to mild side effects was discouraged. The review is designed to help clinicians put these updated guidelines into practice.
Implementing effective hypertensive management--review of the 2014 high blood pressure management guidelines.
2015
South Dakota medicine : the journal of the South Dakota State Medical Association
Li S, Kelly SC, Petrasko M
Plain English This article summarizes the 2014 JNC 8 blood pressure guidelines, which updated treatment targets based on patient risk category. Patients at lower risk (over 60 without major complications) now have a target of 150/90 mmHg, while high-risk patients (those with kidney disease, diabetes, or under 60) target 140/90 mmHg, with first-line drug options including diuretics, calcium channel blockers, ACE inhibitors, and ARBs. The practical review helps clinicians apply these changes in everyday care.
Stenting of the unprotected left main coronary artery in a nonagenarian presenting with recurrent non-ST elevation myocardial infarction.
2014
South Dakota medicine : the journal of the South Dakota State Medical Association
Raizada A, Petrasko M, Stys TP, Stys AT
Plain English This study looked at a 90-year-old woman who suffered a heart attack and received a stent in a critical artery without using any additional support devices. Despite the risks, the procedure was successful, which is significant in treating elderly patients who might not survive traditional bypass surgery. This research shows that advanced methods can still be effective even in very high-risk cases.
Who this helps: This helps elderly patients with heart issues who may not be suitable for surgery.
Progression of venoconstriction in patients after heart transplantation during exercise.
1994
International journal of cardiology
Petrasko M, Horak J, Prerovsky I
Plain English This study looked at how blood flow and circulation change during exercise in patients who have undergone heart transplantation. Researchers found that as these patients exercised, their blood vessels tightened, which reduced the capacity of their veins to hold blood. For example, their venous compliance dropped significantly from 0.0454 to 0.0309 ml/mmHg, while healthy individuals showed no such changes and maintained a stable compliance around 0.0833 ml/mmHg at rest and during exercise. Understanding these changes is important because they can help improve care for heart transplant patients, particularly in managing their blood flow during physical activities.
Who this helps: Heart transplant patients.
Impaired venodilatation due to nitroglycerine in patients after heart transplantation.
1991
International angiology : a journal of the International Union of Angiology
Petrasko M, Prerovský I, Kocandrle V
Plain English This study looked at how nitroglycerin affects blood vessels in three groups: patients who had a heart transplant, those with severe heart failure, and a healthy control group. While all groups showed similar widening of the arteries after using nitroglycerin, only the healthy group experienced significant vein dilation, indicating that patients after heart transplant and those with severe heart failure had problems with vein relaxation. This finding is important as it highlights a specific issue in patients with heart transplants and severe heart failure that might affect their treatment options.
Who this helps: Doctors treating patients with heart transplants or severe heart failure.
Vasoconstriction in patients after heart transplantation.
1990
International journal of cardiology
Petrasko M, Prerovský I, Fabián J, Kocandrle V
Plain English This study looked at blood flow in the arms of three groups of people: those who had heart transplants, those with severe heart problems, and healthy individuals. Researchers found that transplanted patients experienced some tightening of blood vessels, but it wasn’t as severe as in those with heart failure. Overall, blood flow and resistance levels after a brief period of reduced blood flow were similar between the transplant patients and healthy individuals, indicating that issues with blood vessel tightening can be resolved in transplant patients.
Who this helps: This research benefits heart transplant patients by improving understanding of their blood flow regulation.
[Central and peripheral circulation in patients after orthotopic transplantation of the heart].
1989
Vnitrni lekarstvi
Fabián J, Horák J, Prerovský I, Petrasko M, Kocandrle V
Plain English This study looked at how heart transplantation affects blood flow in the body by examining 12 patients (11 men and 1 woman, average age 44) at different times after their surgeries. Researchers found that while the heart functioned normally at rest, it responded slowly to exercise, with increased pressure in the heart's chambers and pulmonary artery, suggesting challenges in how easily blood moves. This is important because it helps us understand how a transplanted heart manages blood circulation and can guide better care for patients after surgery.
Who this helps: This helps patients who have undergone heart transplants and their healthcare providers.